| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acromegaly
|
Melmed, Shlomo
|
|
1996
|
|
S1 |
p. 51-52
2 p.
|
artikel
|
| 2 |
Acromegaly—the place of the neurosurgeon
|
Fahlbusch, R.
|
|
1996
|
|
S1 |
p. 65-66
2 p.
|
artikel
|
| 3 |
A natural history of botanical therapeutics
|
Schmidt, Barbara
|
|
2008
|
|
S1 |
p. S3-S9
7 p.
|
artikel
|
| 4 |
Attenuation of diabetes-associated mesenteric vascular hypertrophy with perindopril: Morphological and molecular biological studies
|
Cooper, Mark E.
|
|
1998
|
|
S1 |
p. 24-27
4 p.
|
artikel
|
| 5 |
Australian diabetes screening study: Impaired glucose tolerance and non—insulin-dependent diabetes mellitus
|
Welborn, Timothy A.
|
|
1997
|
|
S1 |
p. 35-39
5 p.
|
artikel
|
| 6 |
Benefits of gliclazide in the atherosclerotic process: decrease in monocyte adhesion to endothelial cells
|
Renier, Geneviève
|
|
2003
|
|
S1 |
p. 13-18
6 p.
|
artikel
|
| 7 |
Binding properties of somatostatin receptor subtypes
|
Bruns, Christian
|
|
1996
|
|
S1 |
p. 17-20
4 p.
|
artikel
|
| 8 |
Bioactives of Artemisia dracunculus L enhance cellular insulin signaling in primary human skeletal muscle culture
|
Wang, Zhong Q.
|
|
2008
|
|
S1 |
p. S58-S64
7 p.
|
artikel
|
| 9 |
Blockade of growth factor synthesis and growth factor action: Two possible sites of interference in allograft vessel disease and coronary bypass or balloon injury
|
Häyry, P.
|
|
1996
|
|
S1 |
p. 101-103
3 p.
|
artikel
|
| 10 |
Botanicals and cardiometabolic risk: positioning science to address the hype
|
Cefalu, William T.
|
|
2008
|
|
S1 |
p. S1-S2
2 p.
|
artikel
|
| 11 |
Botanicals as epigenetic modulators for mechanisms contributing to development of metabolic syndrome
|
Kirk, Heather
|
|
2008
|
|
S1 |
p. S16-S23
8 p.
|
artikel
|
| 12 |
Cardiovascular aspects in acromegaly: Effects of treatment
|
Lombardi, Gaetano
|
|
1996
|
|
S1 |
p. 57-60
4 p.
|
artikel
|
| 13 |
Cellular abnormalities in pituitary tumors
|
Spada, Anna
|
|
1996
|
|
S1 |
p. 46-48
3 p.
|
artikel
|
| 14 |
Chest pain of cardiac and noncardiac origin
|
Lenfant, Claude
|
|
2010
|
|
S1 |
p. S41-S46
6 p.
|
artikel
|
| 15 |
Clinical and medical diagnosis of acromegaly
|
Lamberts, S.W.J.
|
|
1995
|
|
S1 |
p. 15-17
3 p.
|
artikel
|
| 16 |
Comprehensive management of acromegaly
|
Melmed, S.
|
|
1995
|
|
S1 |
p. 27-30
4 p.
|
artikel
|
| 17 |
Contents
|
|
|
2008
|
|
S1 |
p. A1-
1 p.
|
artikel
|
| 18 |
Diabetes mellitus and vascular lesions
|
Hayoz, Daniel
|
|
1998
|
|
S1 |
p. 16-19
4 p.
|
artikel
|
| 19 |
Does treatment of acromegaly affect life expectancy?
|
Bates, A.S.
|
|
1995
|
|
S1 |
p. 1-5
5 p.
|
artikel
|
| 20 |
Editorial Board
|
|
|
1995
|
|
S1 |
p. vi-
1 p.
|
artikel
|
| 21 |
Effect of angiotensin-converting enzyme inhibition with perindopril and β-blockade with atenolol on retinal blood flow in hypertensive diabetic subjects
|
Patel, V.
|
|
1998
|
|
S1 |
p. 28-33
6 p.
|
artikel
|
| 22 |
Effect of Shilianhua extract and its fractions on body weight of obese mice
|
Yin, Jun
|
|
2008
|
|
S1 |
p. S47-S51
5 p.
|
artikel
|
| 23 |
Effector coupling of somatostatin receptor subtypes on human endocrine tumors
|
Kubota, Akira
|
|
1996
|
|
S1 |
p. 42-45
4 p.
|
artikel
|
| 24 |
Effects of angiotensin-converting enzyme inhibition on vascular remodeling of resistance vessels in hypertensive patients
|
Mulvany, Michael J.
|
|
1998
|
|
S1 |
p. 20-23
4 p.
|
artikel
|
| 25 |
Effects of gliclazide beyond metabolic control
|
Ceriello, Antonio
|
|
2006
|
|
S1 |
p. S10-S15
6 p.
|
artikel
|
| 26 |
Effects of intramuscular microsphere-encapsulated octreotide on serum growth hormone, insulin-like growth factors (IGFs), free IGFs, and IGF-binding proteins in acromegalic patients
|
Kaal, A.
|
|
1995
|
|
S1 |
p. 6-14
9 p.
|
artikel
|
| 27 |
Effects of perindopril on renal histomorphometry in diabetic subjects with microalbuminuria: A 3-year placebo-controlled biopsy study
|
Nankervis, A.
|
|
1998
|
|
S1 |
p. 12-15
4 p.
|
artikel
|
| 28 |
Effects of soy protein and isoflavones on insulin resistance and adiponectin in male monkeys
|
Wagner, Janice D.
|
|
2008
|
|
S1 |
p. S24-S31
8 p.
|
artikel
|
| 29 |
Etiology of acromegaly: A molecular biological approach
|
Spada, A.
|
|
1995
|
|
S1 |
p. 31-33
3 p.
|
artikel
|
| 30 |
Fibromyalgia and the complex regional pain syndrome: similarities in pathophysiology and treatment
|
Wurtman, Richard J.
|
|
2010
|
|
S1 |
p. S37-S40
4 p.
|
artikel
|
| 31 |
Foreword
|
Tremblay-Servier, Madeleine
|
|
2010
|
|
S1 |
p. S1-
1 p.
|
artikel
|
| 32 |
Gene expression microarray analysis of the effects of grape anthocyanins in mice: a test of a hypothesis-generating paradigm
|
Lefevre, Michael
|
|
2008
|
|
S1 |
p. S52-S57
6 p.
|
artikel
|
| 33 |
Genetics of pain, opioids, and opioid responsiveness
|
Tremblay, Johanne
|
|
2010
|
|
S1 |
p. S5-S8
4 p.
|
artikel
|
| 34 |
Gliclazide modified release: a critical review of pharmacodynamic, metabolic, and vasoprotective effects
|
Schernthaner, Guntram
|
|
2003
|
|
S1 |
p. 29-34
6 p.
|
artikel
|
| 35 |
Gliclazide treatment of streptozotocin diabetic rats restores GLUT4 protein content and basal glucose uptake in skeletal muscle
|
Pulido, Nieves
|
|
1997
|
|
S1 |
p. 10-13
4 p.
|
artikel
|
| 36 |
Glycation, oxidation, and lipoxidation in the development of diabetic complications
|
Kennedy, A.Laurence
|
|
1997
|
|
S1 |
p. 14-21
8 p.
|
artikel
|
| 37 |
Gout: epitome of painful arthritis
|
VanItallie, Theodore B.
|
|
2010
|
|
S1 |
p. S32-S36
5 p.
|
artikel
|
| 38 |
Granulomas in murine schistosomiasis mansoni have a somatostatin immunoregulatory circuit
|
Elliott, D.E.
|
|
1996
|
|
S1 |
p. 88-90
3 p.
|
artikel
|
| 39 |
Gs protein mutations and pituitary tumors: Functional correlates and possible therapeutic implications
|
Faglia, G.
|
|
1996
|
|
S1 |
p. 117-119
3 p.
|
artikel
|
| 40 |
Gs protein mutations and the pathogenesis and function of pituitary tumors
|
Harris, P.E.
|
|
1996
|
|
S1 |
p. 120-122
3 p.
|
artikel
|
| 41 |
How to ADVANCE prevention of cardiovascular complications in type 2 diabetes
|
Grobbee, Diederick E
|
|
2003
|
|
S1 |
p. 24-28
5 p.
|
artikel
|
| 42 |
Improved analogs and novel delivery systems for somatostatin octapeptides
|
Moreau, J.-P.
|
|
1996
|
|
S1 |
p. 24-26
3 p.
|
artikel
|
| 43 |
Intensified multifactorial intervention and cardiovascular outcome in type 2 diabetes: the Steno-2 study
|
Pedersen, Oluf
|
|
2003
|
|
S1 |
p. 19-23
5 p.
|
artikel
|
| 44 |
Ischemia in type 2 diabetes: tissue selectivity of sulfonylureas and clinical implications
|
Wascher, Thomas C
|
|
2003
|
|
S1 |
p. 3-5
3 p.
|
artikel
|
| 45 |
Ischemic heart disease in type 2 diabetes
|
Otel, Irina
|
|
2003
|
|
S1 |
p. 6-12
7 p.
|
artikel
|
| 46 |
Is there a role for somatostatin and its analogs in Cushing's syndrome?
|
de Herder, W.W.
|
|
1996
|
|
S1 |
p. 83-85
3 p.
|
artikel
|
| 47 |
Long-term effects of radiotherapy for acromegaly
|
Wass, J.A.H.
|
|
1996
|
|
S1 |
p. 107-108
2 p.
|
artikel
|
| 48 |
Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective
|
Holman, Rury R.
|
|
2006
|
|
S1 |
p. S2-S5
4 p.
|
artikel
|
| 49 |
Management of newly diagnosed non-insulin-dependent diabetes mellitus in the primary care setting: effects of 2 years of gliclazide treatment— the diadem study
|
Cathelineau, Gérard
|
|
1997
|
|
S1 |
p. 31-34
4 p.
|
artikel
|
| 50 |
Masthead
|
|
|
2003
|
|
S1 |
p. IFC-
1 p.
|
artikel
|
| 51 |
Masthead
|
|
|
2010
|
|
S1 |
p. IFC-
1 p.
|
artikel
|
| 52 |
Masthead
|
|
|
2008
|
|
S1 |
p. IFC-
1 p.
|
artikel
|
| 53 |
Masthead
|
|
|
2006
|
|
S1 |
p. CO2-
1 p.
|
artikel
|
| 54 |
Metabolic abnormalities in impaired glucose tolerance
|
Gerich, John E.
|
|
1997
|
|
S1 |
p. 40-43
4 p.
|
artikel
|
| 55 |
Metabolic aspects of acromegaly and its treatment
|
Quabbe, H.-J.
|
|
1996
|
|
S1 |
p. 61-62
2 p.
|
artikel
|
| 56 |
Microvascular permeability with sulfonylureas in normal and diabetic hamsters
|
Bouskela, Eliete
|
|
1997
|
|
S1 |
p. 26-30
5 p.
|
artikel
|
| 57 |
Modulation of peroxisome proliferator–activated receptor γ stability and transcriptional activity in adipocytes by resveratrol
|
Floyd, Z. Elizabeth
|
|
2008
|
|
S1 |
p. S32-S38
7 p.
|
artikel
|
| 58 |
Molecular and functional properties of somatostatin receptor subtypes
|
Liapakis, George
|
|
1996
|
|
S1 |
p. 12-13
2 p.
|
artikel
|
| 59 |
Molecular biology of somatostatin receptor subtypes
|
Patel, Yogesh C.
|
|
1996
|
|
S1 |
p. 31-38
8 p.
|
artikel
|
| 60 |
Molecular mechanisms of antiproliferative effect of somatostatin: Involvement of a tyrosine phosphatase
|
Lopez, F.
|
|
1996
|
|
S1 |
p. 14-16
3 p.
|
artikel
|
| 61 |
Multifactorial aspects of the treatment of the type II diabetic patient
|
Colwell, John A.
|
|
1997
|
|
S1 |
p. 1-4
4 p.
|
artikel
|
| 62 |
Neurosurgical treatments of intractable pain
|
Nicolaidis, Stylianos
|
|
2010
|
|
S1 |
p. S27-S31
5 p.
|
artikel
|
| 63 |
New insights into the regulation of somatotrope function using genetic and transgenic models
|
Frohman, L.A.
|
|
1996
|
|
S1 |
p. 1-3
3 p.
|
artikel
|
| 64 |
New therapeutics for pain—an overview
|
Kalia, Madhu
|
|
2010
|
|
S1 |
p. S2-S4
3 p.
|
artikel
|
| 65 |
Nonfunctioning adenomas of the pituitary
|
Liuzzi, Antonio
|
|
1996
|
|
S1 |
p. 80-82
3 p.
|
artikel
|
| 66 |
Observations on the stimulation of growth hormone secretion in patients with growth hormone deficiency
|
Kendall-Taylor, P.
|
|
1996
|
|
S1 |
p. 127-128
2 p.
|
artikel
|
| 67 |
Opioids for cancer pain: the challenge of optimizing treatment
|
Plante, Gérard E.
|
|
2010
|
|
S1 |
p. S47-S52
6 p.
|
artikel
|
| 68 |
Overcoming the hurdles to achieving glycemic control
|
Shaw, Kenneth M.
|
|
2006
|
|
S1 |
p. S6-S9
4 p.
|
artikel
|
| 69 |
Pain: sex differences and implications for treatment
|
Manson, JoAnn E.
|
|
2010
|
|
S1 |
p. S16-S20
5 p.
|
artikel
|
| 70 |
Pathophysiology of diabetic nephropathy
|
Cooper, Mark E.
|
|
1998
|
|
S1 |
p. 3-6
4 p.
|
artikel
|
| 71 |
Presurgical octreotide: Treatment in acromegaly
|
Stevenaert, Achille
|
|
1996
|
|
S1 |
p. 72-74
3 p.
|
artikel
|
| 72 |
Progress in diabetes care: Introduction
|
Mogensen, C.E.
|
|
1998
|
|
S1 |
p. 1-2
2 p.
|
artikel
|
| 73 |
Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet
|
Stewart, Laura K.
|
|
2008
|
|
S1 |
p. S39-S46
8 p.
|
artikel
|
| 74 |
Receptor-specific somatostatin analogs: Correlations with biological activity
|
Coy, David H.
|
|
1996
|
|
S1 |
p. 21-23
3 p.
|
artikel
|
| 75 |
Regulation of somatostatin gene transcription by cyclic adenosine monophosphate
|
Montminy, M.
|
|
1996
|
|
S1 |
p. 4-7
4 p.
|
artikel
|
| 76 |
Relationships between pathological diagnosis and clinical parameters in acromegaly
|
Trouillas, J.
|
|
1996
|
|
S1 |
p. 53-56
4 p.
|
artikel
|
| 77 |
Role of angiotensin-converting enzyme inhibition in glucose metabolism and renal injury in diabetes
|
Velasquez, Manuel T.
|
|
1998
|
|
S1 |
p. 7-11
5 p.
|
artikel
|
| 78 |
Role of the new growth hormone-releasing secretagogues in the diagnosis of some hypothalamopituitary pathologies
|
Casanueva, Felipe F.
|
|
1996
|
|
S1 |
p. 123-126
4 p.
|
artikel
|
| 79 |
Sandostatin® LAR®: A promising therapeutic tool in the management of acromegalic patients
|
Lancranjan, I.
|
|
1996
|
|
S1 |
p. 67-71
5 p.
|
artikel
|
| 80 |
Sandostatin® LAR® (microencapsulated octreotide acetate) in acromegaly: Pharmacokinetic and pharmacodynamic relationships
|
Grass, Peter
|
|
1996
|
|
S1 |
p. 27-30
4 p.
|
artikel
|
| 81 |
Sandostatin LAR®: Pharmacokinetics, pharmacodynamics, efficacy, and tolerability in acromegalic patients
|
Lancranjan, Ioana
|
|
1995
|
|
S1 |
p. 18-26
9 p.
|
artikel
|
| 82 |
Somatostatin analogs: Future directions
|
Lamberts, S.W.J.
|
|
1996
|
|
S1 |
p. 104-106
3 p.
|
artikel
|
| 83 |
Somatostatin analogs in ectopic corticotropin production
|
von Werder, K.
|
|
1996
|
|
S1 |
p. 129-131
3 p.
|
artikel
|
| 84 |
Somatostatin and cancer
|
Robbins, R.J.
|
|
1996
|
|
S1 |
p. 98-100
3 p.
|
artikel
|
| 85 |
Somatostatin, growth hormone, insulin-like growth factor-1, and diabetes: Friends or foes?
|
Ørskov, H.
|
|
1996
|
|
S1 |
p. 91-95
5 p.
|
artikel
|
| 86 |
Somatostatin receptor expression in clinical immunology
|
van Hagen, P.M.
|
|
1996
|
|
S1 |
p. 86-87
2 p.
|
artikel
|
| 87 |
Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels
|
Reubi, Jean Claude
|
|
1996
|
|
S1 |
p. 39-41
3 p.
|
artikel
|
| 88 |
Somatostatin receptor subtypes: Specific expression and signaling properties
|
Schonbrunn, A.
|
|
1996
|
|
S1 |
p. 8-11
4 p.
|
artikel
|
| 89 |
Spinal glia and chronic pain
|
O'Callaghan, James P.
|
|
2010
|
|
S1 |
p. S21-S26
6 p.
|
artikel
|
| 90 |
Stereotactic radiosurgery of pituitary adenomas
|
Motti, E.D.F.
|
|
1996
|
|
S1 |
p. 111-114
4 p.
|
artikel
|
| 91 |
Strategies for assessment of botanical action on metabolic syndrome in the mouse and evidence for a genotype-specific effect of Russian tarragon in the regulation of insulin sensitivity
|
Zuberi, Aamir R.
|
|
2008
|
|
S1 |
p. S10-S15
6 p.
|
artikel
|
| 92 |
Sulfonylureas and the risk of myocardial infarction
|
Thisted, Henriette
|
|
2006
|
|
S1 |
p. S16-S19
4 p.
|
artikel
|
| 93 |
Sulfonylureas in the therapy of type 2 diabetes mellitus: where do we stand today?
|
Prato, Stefano Del
|
|
2006
|
|
S1 |
p. S1-
1 p.
|
artikel
|
| 94 |
Surgical therapy of pituitary adenomas
|
Giovanelli, Massimo
|
|
1996
|
|
S1 |
p. 115-116
2 p.
|
artikel
|
| 95 |
Table of contents
|
|
|
2003
|
|
S1 |
p. A1-
1 p.
|
artikel
|
| 96 |
Table of Contents
|
|
|
2010
|
|
S1 |
p. A1-
1 p.
|
artikel
|
| 97 |
Table of Contents
|
|
|
2006
|
|
S1 |
p. A1-
1 p.
|
artikel
|
| 98 |
The added value of therapy in diabetes: The education of patients for self-management of their disease
|
Assal, Jean-Philippe
|
|
1997
|
|
S1 |
p. 61-64
4 p.
|
artikel
|
| 99 |
The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro
|
O'Brien, Richard C.
|
|
1997
|
|
S1 |
p. 22-25
4 p.
|
artikel
|
| 100 |
The effects of the somatostatin analog octreotide on angiogenesis in vitro
|
Danesi, Romano
|
|
1996
|
|
S1 |
p. 49-50
2 p.
|
artikel
|
| 101 |
The fasting hyperglycaemia study: III. Randomized controlled trial of sulfonylurea therapy in subjects with increased but not diabetic fasting plasma glucose
|
Karunakara, S.
|
|
1997
|
|
S1 |
p. 56-60
5 p.
|
artikel
|
| 102 |
The fasting hyperglycaemia study: II. Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose
|
Dyson, P.A.
|
|
1997
|
|
S1 |
p. 50-55
6 p.
|
artikel
|
| 103 |
The fasting hyperglycaemia study: I. Subject identification and recruitment for a non—insulin-dependent diabetes prevention trial
|
Hammersley, M.S.
|
|
1997
|
|
S1 |
p. 44-49
6 p.
|
artikel
|
| 104 |
The place of sulfonylureas in the therapy for type 2 diabetes mellitus
|
Del Prato, Stefano
|
|
2006
|
|
S1 |
p. S20-S27
8 p.
|
artikel
|
| 105 |
The relevance of somatostatin receptor expression in malignant lymphomas
|
van den Anker-Lugtenburg, P.J.
|
|
1996
|
|
S1 |
p. 96-97
2 p.
|
artikel
|
| 106 |
The role of corticosteroids and stress in chronic pain conditions
|
McEwen, Bruce S.
|
|
2010
|
|
S1 |
p. S9-S15
7 p.
|
artikel
|
| 107 |
The role of somatostatin agonistic analogs in the treatment of acromegaly
|
Tolis, George
|
|
1996
|
|
S1 |
p. 109-110
2 p.
|
artikel
|
| 108 |
The stimulation of insulin secretion in non—insulin-dependent diabetic patients by amino acids and gliclazide in the basal and hyperglycemic state
|
Matthews, D.R.
|
|
1997
|
|
S1 |
p. 5-9
5 p.
|
artikel
|
| 109 |
Thyrotropin-secreting pituitary adenomas
|
Beck-Peccoz, P.
|
|
1996
|
|
S1 |
p. 75-78
4 p.
|
artikel
|
| 110 |
Treatment options for acromegaly
|
Sheppard, M.C.
|
|
1996
|
|
S1 |
p. 63-64
2 p.
|
artikel
|
| 111 |
Type 2 diabetes management: putting theory into practice—introduction
|
Charbonnel, Bernard
|
|
2003
|
|
S1 |
p. 1-2
2 p.
|
artikel
|
Tijdschrift beschrijving